Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-05-05FDA Approved: FENOFIBRATE — Original Application (Aurobindo Pharma Limited)
FDA approves the original application (ANDA) for Fenofibrate manufactured by Aurobindo Pharma Limited, authorizing its generic fenofibrate p…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: The Therapeutic Effects of Statins and Berberine on the Hyperlipemia [Phase 4]
A Phase 4 trial evaluating the therapeutic effects of statins and berberine on hyperlipidemia/dyslipidemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years [NA]
Clinical trial update evaluating caloric restriction and resveratrol effects on the sirtuin system in adults aged 55-65; results have been p…
-
FDA approval · 2016-04-06FDA Approved: LOPID — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for Lopid (gemfibrozil) submitted by Parke-Davis Div of Pfizer Inc, resulting in an approved modific…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia [Phase 1, Phase 2]
IMPAACT P1063 evaluated the safety and effectiveness of atorvastatin in HIV-infected children and adolescents with hyperlipidemia; the Phase…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance
The document reports the completion of a post-marketing surveillance study evaluating the efficacy and safety of oral probucol tablets in pa…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia [NA]
A completed clinical trial evaluated whether diet, exercise, niacin, and fenofibrate could reduce cardiovascular risk factors in people with…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Effects of Aleurone-enriched Products on Cardiovascular Risk Factors [NA]
A completed clinical trial evaluating aleurone-enriched products and their impact on cardiovascular risk factors, including glucose and lipi…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: The Health Outcomes Management and Evaluation (HOME) Study [Phase 3]
Emory University's Phase 3 HOME study, a health outcomes management and evaluation trial, has completed, with the update outlining its scope…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet [Phase 1]
Phase 1 study to compare the pharmacokinetics of a fixed-dose combination tablet containing fimasartan and atorvastatin.
-
FDA approval · 2016-02-24FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited, authorizing the generic atorvastatin…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin [Phase 1]
Phase 1 pharmacokinetic and safety study of a fixed-dose combination tablet containing fimasartan, amlodipine, and rosuvastatin; the study h…
-
FDA approval · 2016-02-19FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Gemfibrozil filed by Chartwell RX, LLC under an existing ANDA, indicating regulatory approval re…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of K-312 in healthy subjects has completed, with …
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Dietary Treatment of Hyperlipidemia in Women vs. Men
Completed clinical trial evaluating dietary treatment of hyperlipidemia in women versus men.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab [Phase 1]
Phase 1 pharmacokinetic study assessing the impact of severe renal impairment and dialysis on evolocumab.
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of CKD-391 for hyperlipidemia has completed.
-
FDA approval · 2016-01-27FDA Approved: FLUVASTATIN SODIUM — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic fluvastatin sodium as an original ANDA, enabling its use to treat hyperlipidemia and reduce cardiovascular risk.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study. [NA]
A completed pilot trial update assessing the safety and efficacy of PDL-0101 in patients with hyperlipidemia.
-
FDA approval · 2016-01-21FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA approved a supplemental application for gemfibrozil from Exelan Pharmaceuticals, Inc. (ANDA 077836).
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS [NA]
Clinical trial update on the effects of anabolic steroids and protease inhibitors in people living with HIV/AIDS. The study status is comple…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers [Phase 1]
A phase 1 study evaluating the pharmacokinetics and safety of NK-104-CR in healthy adult volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 [Phase 3]
Phase 3 clinical trial evaluating a monoclonal antibody against PCSK9 to lower LDL-C in patients not currently on lipid-lowering therapy; co…
-
FDA approval · 2015-12-23FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for LIPOFEN (fenofibrate) submitted by ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects [Phase 2]
Phase 2 trial evaluating an anti-PCSK9 antibody in statin-intolerant subjects with hyperlipidemia; study completed with results posted.